nicotinamide mononucleotide has been researched along with Cardiotoxicity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; He, B; Huang, R; Wan, Y; Wang, C; Wang, L; Zhu, D; Zhu, J | 1 |
| Badalzadeh, R; Khosroshahi, AJ; Mokhtari, B | 1 |
| Ashok Kumaar, PV; Canault, M; Cannelle, H; Charmetant, J; Cros, C; Grozio, A; Hulo, N; Kuehnemann, C; Margier, M; Morales, J; Verdin, E | 1 |
3 other study(ies) available for nicotinamide mononucleotide and Cardiotoxicity
| Article | Year |
|---|---|
Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Fibrosis; Heart; Inflammasomes; Inflammation; Male; Myocardium; Nicotinamide Mononucleotide; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 2021 |
Combination of nicotinamide mononucleotide and troxerutin induces full protection against doxorubicin-induced cardiotoxicity by modulating mitochondrial biogenesis and inflammatory response.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiotoxicity; Cytokines; Doxorubicin; Hydroxyethylrutoside; Male; Nicotinamide Mononucleotide; Organelle Biogenesis; Oxidative Stress; Rats; Rats, Wistar | 2022 |
Nicotinamide Mononucleotide Administration Prevents Doxorubicin-Induced Cardiotoxicity and Loss in Physical Activity in Mice.
Topics: Animals; Apoptosis; Cardiotoxicity; Doxorubicin; Heart; Mice; Nicotinamide Mononucleotide | 2022 |